These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35328504)

  • 1. Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).
    Nieuwenhuis S; Widomska J; Blom P; 't Hoen PAC; van Engelen BGM; Glennon JC; On Behalf Of The Optimistic Consortium
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.
    Azotla-Vilchis CN; Sanchez-Celis D; Agonizantes-Juárez LE; Suárez-Sánchez R; Hernández-Hernández JM; Peña J; Vázquez-Santillán K; Leyva-García N; Ortega A; Maldonado V; Rangel C; Magaña JJ; Cisneros B; Hernández-Hernández O
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.
    Mazzoli M; Ariatti A; Garuti G; Agnoletto V; Fantini R; Marchioni A; Galassi G
    Acta Neurol Belg; 2021 Feb; 121(1):133-142. PubMed ID: 32651874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1.
    Bérenger-Currias N; Martinat C; Baghdoyan S
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
    van Engelen B;
    Trials; 2015 May; 16():224. PubMed ID: 26002596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swallow-related quality of life and oropharyngeal dysphagia in myotonic dystrophy.
    Pilz W; Passos VL; Verdonschot RJ; Meijers J; Roodenburg N; Halmans Y; Faber CG; Kremer B; Baijens LWJ
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2357-2362. PubMed ID: 32296979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood.
    van Cruchten RTP; van As D; Glennon JC; van Engelen BGM; 't Hoen PAC; ;
    BMC Med; 2022 Nov; 20(1):395. PubMed ID: 36352383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year study of quality of life in myotonic dystrophy.
    Peric S; Vujnic M; Dobricic V; Marjanovic A; Basta I; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Neurol Scand; 2016 Nov; 134(5):346-351. PubMed ID: 27696366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary titin in myotonic dystrophy type 1.
    Varga D; Perecz B; Fülöp K; Sipos A; Janszky JV; Hajdú N; Pál E
    Muscle Nerve; 2023 Aug; 68(2):215-218. PubMed ID: 37291994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome alterations in myotonic dystrophy skeletal muscle and heart.
    Wang ET; Treacy D; Eichinger K; Struck A; Estabrook J; Olafson H; Wang TT; Bhatt K; Westbrook T; Sedehizadeh S; Ward A; Day J; Brook D; Berglund JA; Cooper T; Housman D; Thornton C; Burge C
    Hum Mol Genet; 2019 Apr; 28(8):1312-1321. PubMed ID: 30561649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of early onset diabetes with myotonic dystrophy type 1.
    Wan J; Zhao L; Jin P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 48(6):930-934. PubMed ID: 37587079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of GSK3β-Target Proteins in Skin Fibroblasts of Myotonic Dystrophy Type 1 (DM1) Patients.
    Grande V; Hathazi D; O'Connor E; Marteau T; Schara-Schmidt U; Hentschel A; Gourdon G; Nikolenko N; Lochmüller H; Roos A
    J Neuromuscul Dis; 2021; 8(4):603-619. PubMed ID: 33682722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study.
    Rinninella E; Silvestri G; Cintoni M; Perna A; Martorana GE; De Lorenzo A; Rossini PM; Miggiano GAD; Gasbarrini A; Mele MC
    Nutrition; 2019; 67-68():110546. PubMed ID: 31376676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.